PRT versus IMRT toxicity in Medicare beneficiaries with prostate cancer
There is no difference between proton radiotherapy (PRT) and intensity-modulated radiotherapy (IMRT) when comparing the toxicity among Medicare beneficiary patients with prostate cancer at 12 months post-treatment according ...
Dec 17, 2012
0
1